drugset / Trial / NCT01410201

Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane

NCT01410201 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of dexamethasone intravitreal implant (Ozurdex) in combination with pars plana vitrectomy and membrane peeling for idiopathic epiretinal membrane (ERM).

Timeline

Start
2011-08
Primary completion
2016-01
Completion
2016-01

Outcome

Outcome not reported

Stopped (Enrollment): “recruitment not met”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.7 mg Other